Annual SG&A
$11.66 M
-$454.00 K-3.75%
31 December 2023
Summary:
Tempest Therapeutics annual selling, general & administrative expenses is currently $11.66 million, with the most recent change of -$454.00 thousand (-3.75%) on 31 December 2023. During the last 3 years, it has risen by +$6.75 million (+137.50%). TPST annual SG&A is now -3.75% below its all-time high of $12.11 million, reached on 31 December 2022.TPST Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.99 M
-$751.00 K-20.05%
30 September 2024
Summary:
Tempest Therapeutics quarterly selling, general & administrative expenses is currently $2.99 million, with the most recent change of -$751.00 thousand (-20.05%) on 30 September 2024. Over the past year, it has increased by +$623.00 thousand (+26.28%). TPST quarterly SG&A is now -20.05% below its all-time high of $3.75 million, reached on 30 June 2024.TPST Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$714.46 M
-$35.52 M-5.23%
30 September 2024
Summary:
Tempest Therapeutics TTM selling, general & administrative expenses is currently -$714.46 million, with the most recent change of -$35.52 million (-5.23%) on 30 September 2024. Over the past year, it has dropped by -$725.93 million (-6330.03%). TPST TTM SG&A is now -895.61% below its all-time high of $13.70 million, reached on 30 September 2024.TPST TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.8% | +26.3% | -6330.0% |
| 3 y3 years | +137.5% | -3.6% | -8482.7% |
| 5 y5 years | - | - | - |
TPST Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.8% | +137.5% | -20.1% | +26.3% | -187.8% | at low |
| 5 y | 5 years | -3.8% | +137.5% | -20.1% | +161.7% | -895.6% | at low |
| alltime | all time | -3.8% | +137.5% | -20.1% | +161.7% | -895.6% | at low |
Tempest Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.99 M(-20.1%) | $13.70 M(+4.8%) |
| June 2024 | - | $3.75 M(+3.1%) | $13.08 M(+5.6%) |
| Mar 2024 | - | $3.63 M(+9.1%) | $12.39 M(+6.3%) |
| Dec 2023 | $11.66 M(-3.7%) | $3.33 M(+40.5%) | $11.66 M(+1.7%) |
| Sept 2023 | - | $2.37 M(-22.4%) | $11.47 M(-3.6%) |
| June 2023 | - | $3.05 M(+5.2%) | $11.89 M(-0.6%) |
| Mar 2023 | - | $2.90 M(-7.5%) | $11.96 M(-1.2%) |
| Dec 2022 | $12.11 M | $3.14 M(+12.2%) | $12.11 M(+4.5%) |
| Sept 2022 | - | $2.80 M(-10.4%) | $11.60 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $3.12 M(+2.3%) | $11.90 M(+5.0%) |
| Mar 2022 | - | $3.05 M(+16.4%) | $11.34 M(+15.4%) |
| Dec 2021 | $9.82 M(+100.0%) | $2.62 M(-15.6%) | $9.82 M(+15.2%) |
| Sept 2021 | - | $3.11 M(+21.5%) | $8.52 M(+29.5%) |
| June 2021 | - | $2.56 M(+66.5%) | $6.58 M(+27.3%) |
| Mar 2021 | - | $1.53 M(+15.8%) | $5.17 M(+42.3%) |
| Dec 2020 | $4.91 M | $1.33 M(+14.0%) | $3.63 M(+57.5%) |
| Sept 2020 | - | $1.16 M(+1.7%) | $2.31 M(+101.7%) |
| June 2020 | - | $1.14 M | $1.14 M |
FAQ
- What is Tempest Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Tempest Therapeutics?
- What is Tempest Therapeutics annual SG&A year-on-year change?
- What is Tempest Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly SG&A year-on-year change?
- What is Tempest Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Tempest Therapeutics?
- What is Tempest Therapeutics TTM SG&A year-on-year change?
What is Tempest Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of TPST is $11.66 M
What is the all time high annual SG&A for Tempest Therapeutics?
Tempest Therapeutics all-time high annual selling, general & administrative expenses is $12.11 M
What is Tempest Therapeutics annual SG&A year-on-year change?
Over the past year, TPST annual selling, general & administrative expenses has changed by -$454.00 K (-3.75%)
What is Tempest Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of TPST is $2.99 M
What is the all time high quarterly SG&A for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly selling, general & administrative expenses is $3.75 M
What is Tempest Therapeutics quarterly SG&A year-on-year change?
Over the past year, TPST quarterly selling, general & administrative expenses has changed by +$623.00 K (+26.28%)
What is Tempest Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of TPST is -$714.46 M
What is the all time high TTM SG&A for Tempest Therapeutics?
Tempest Therapeutics all-time high TTM selling, general & administrative expenses is $13.70 M
What is Tempest Therapeutics TTM SG&A year-on-year change?
Over the past year, TPST TTM selling, general & administrative expenses has changed by -$725.93 M (-6330.03%)